Overexpression of MRP4 (ABCC4) and MRP5 (ABCC5) confer resistance to the nucleoside analogs cytarabine and troxacitabine, but not gemcitabine

A.D. Adema; K. Floor; K. Smid; R.J. Honeywell; G.L. Scheffer; G. Jansen; G.J. Peters

doi:10.1186/2193-1801-3-732

Overexpression of MRP4 (ABCC4) and MRP5 (ABCC5) confer resistance to the nucleoside analogs cytarabine and troxacitabine, but not gemcitabine

A.D. Adema, K. Floor, K. Smid, R.J. Honeywell, G.L. Scheffer, G. Jansen, G.J. Peters

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Article number	732
Journal	SpringerPlus
Volume	3
DOIs	https://doi.org/10.1186/2193-1801-3-732
Publication status	Published - 2014

Access to Document

10.1186/2193-1801-3-732

Cite this

@article{5d5a6ee1a47b4028bf9b9e77a25c2402,

title = "Overexpression of MRP4 (ABCC4) and MRP5 (ABCC5) confer resistance to the nucleoside analogs cytarabine and troxacitabine, but not gemcitabine",

author = "A.D. Adema and K. Floor and K. Smid and R.J. Honeywell and G.L. Scheffer and G. Jansen and G.J. Peters",

year = "2014",

doi = "10.1186/2193-1801-3-732",

language = "Undefined/Unknown",

volume = "3",

journal = "SpringerPlus",

issn = "2193-1801",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

TY - JOUR

T1 - Overexpression of MRP4 (ABCC4) and MRP5 (ABCC5) confer resistance to the nucleoside analogs cytarabine and troxacitabine, but not gemcitabine

AU - Adema, A.D.

AU - Floor, K.

AU - Smid, K.

AU - Honeywell, R.J.

AU - Scheffer, G.L.

AU - Jansen, G.

AU - Peters, G.J.

PY - 2014

Y1 - 2014

U2 - 10.1186/2193-1801-3-732

DO - 10.1186/2193-1801-3-732

M3 - Article

SN - 2193-1801

VL - 3

JO - SpringerPlus

JF - SpringerPlus

M1 - 732

ER -